Your browser doesn't support javascript.
loading
Clostridium butyricum and Clostridium tyrobutyricum: angel or devil for necrotizing enterocolitis?
Tao, Ruizhi; Zong, Gangfan; Pan, Yehua; Li, Hongxing; Cheng, Peng; Deng, Rui; Chen, Wenxing; Wang, Aiyun; Xia, Shishan; Tang, Weibing; Lu, Yin; Wei, Zhonghong.
Affiliation
  • Tao R; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Zong G; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Pan Y; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Li H; Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Cheng P; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Deng R; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Chen W; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Wang A; Jiangsu Joint International Research Laboratory of Chinese Medicine and Regenerative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Xia S; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
  • Tang W; Jiangsu Joint International Research Laboratory of Chinese Medicine and Regenerative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Lu Y; Ningbo Women and Children's Hospital, Ningbo, China.
  • Wei Z; Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, Nanjing, China.
mSystems ; 8(6): e0073223, 2023 Dec 21.
Article in En | MEDLINE | ID: mdl-37921463
IMPORTANCE: This study sheds light on that treatment with Clostridium tyrobutyricum but not Clostridium butyricum is entitled to protect against necrotizing enterocolitis (NEC) development potentially. The mechanisms behind the opposite effect on NEC may result in different modulation on the level of Akkermansia muciniphila, which is deeply associated with intestinal homoeostasis. Briefly, through improving the abundance of A. muciniphila to alleviate intestinal inflammation and enhance intestinal barrier integrity, C. tyrobutyricum supplement may become a promising therapy for NEC.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Probiotics / Enterocolitis, Necrotizing / Clostridium butyricum / Clostridium tyrobutyricum / Fetal Diseases / Infant, Newborn, Diseases Limits: Female / Humans / Newborn Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Probiotics / Enterocolitis, Necrotizing / Clostridium butyricum / Clostridium tyrobutyricum / Fetal Diseases / Infant, Newborn, Diseases Limits: Female / Humans / Newborn Language: En Year: 2023 Type: Article